The Allstate Corporation $ALL Shares Purchased by Franklin Resources Inc.

Franklin Resources Inc. raised its stake in The Allstate Corporation (NYSE:ALL) by 2.5% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,670,113 shares of the insurance provider’s stock after acquiring an additional 112,858 shares during the period. Franklin Resources Inc. owned 1.77% of Allstate worth $940,140,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Brighton Jones LLC grew its stake in Allstate by 60.2% during the 4th quarter. Brighton Jones LLC now owns 6,500 shares of the insurance provider’s stock worth $1,253,000 after buying an additional 2,443 shares during the last quarter. Revolve Wealth Partners LLC acquired a new position in Allstate during the 4th quarter valued at about $231,000. IFP Advisors Inc boosted its stake in Allstate by 15.4% during the 1st quarter. IFP Advisors Inc now owns 1,032 shares of the insurance provider’s stock valued at $214,000 after purchasing an additional 138 shares during the period. Crestwood Advisors Group LLC grew its position in Allstate by 23.1% in the 1st quarter. Crestwood Advisors Group LLC now owns 1,514 shares of the insurance provider’s stock worth $314,000 after purchasing an additional 284 shares during the last quarter. Finally, Choreo LLC increased its stake in shares of Allstate by 3.9% in the first quarter. Choreo LLC now owns 6,726 shares of the insurance provider’s stock valued at $1,399,000 after purchasing an additional 253 shares during the period. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Allstate

In other news, insider Suren Gupta sold 400 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $215.22, for a total transaction of $86,088.00. Following the sale, the insider directly owned 100,646 shares in the company, valued at approximately $21,661,032.12. The trade was a 0.40% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 1.70% of the company’s stock.

Allstate Trading Up 0.9%

Shares of ALL stock opened at $211.87 on Friday. The firm has a market capitalization of $55.44 billion, a P/E ratio of 9.96, a price-to-earnings-growth ratio of 0.69 and a beta of 0.35. The Allstate Corporation has a 1 year low of $176.00 and a 1 year high of $215.70. The firm’s fifty day simple moving average is $203.11 and its 200 day simple moving average is $201.98. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37.

Allstate (NYSE:ALL) last posted its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.48 by $5.69. The company had revenue of $17.26 billion for the quarter, compared to analyst estimates of $16.59 billion. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The business’s quarterly revenue was up 3.8% on a year-over-year basis. During the same period last year, the business posted $3.91 EPS. As a group, sell-side analysts predict that The Allstate Corporation will post 18.74 EPS for the current year.

Allstate Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Monday, December 1st will be given a $1.00 dividend. The ex-dividend date is Monday, December 1st. This represents a $4.00 dividend on an annualized basis and a dividend yield of 1.9%. Allstate’s dividend payout ratio (DPR) is currently 12.95%.

Analysts Set New Price Targets

A number of equities analysts have issued reports on ALL shares. Roth Capital set a $230.00 price target on Allstate and gave the company a “buy” rating in a research note on Friday, September 26th. Keefe, Bruyette & Woods upped their price target on shares of Allstate from $246.00 to $250.00 and gave the company an “outperform” rating in a report on Tuesday, November 11th. Barclays reaffirmed an “underweight” rating and issued a $198.00 price objective (up previously from $188.00) on shares of Allstate in a research note on Thursday, July 31st. Weiss Ratings reissued a “buy (b)” rating on shares of Allstate in a research note on Wednesday, October 8th. Finally, Raymond James Financial restated a “strong-buy” rating and issued a $260.00 price target (up previously from $250.00) on shares of Allstate in a research report on Monday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $237.64.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.